Why Stage 2 Breast Cancer Often Requires Pre-Surgery Treatment
Stage 2 breast cancer is still considered treatable with a high chance of cure if managed properly. One common approach is neoadjuvant therapy (pre-surgery treatment), which may include chemotherapy, targeted therapy, or immunotherapy.
Why Doctors Recommend Pre-Surgery Treatment
1. Shrink the tumor size
Makes surgery easier and increases the chance of breast-conserving surgery instead of mastectomy.
2. Assess treatment response
Helps doctors decide if the chosen drug works well or if it needs to be adjusted before surgery.
3. Reduce risk of spread
Eliminates hidden cancer cells that might have already spread.
4. Beneficial for certain subtypes
Such as HER2-positive and triple-negative breast cancers, which tend to grow aggressively.
5. Facilitates comprehensive planning
Ensures better coordination of surgery, radiation, and systemic therapy for the best outcomes.
summarize
Neoadjuvant therapy in stage 2 breast cancer is not only about shrinking the tumor but also about reducing recurrence risk, improving treatment precision, and giving patients a higher chance of survival with better quality of life
